Skip to main content
Signal8

MCANDREW STEPHEN J

SEC insider (Form 3/4/5 filer). CIK 0001227041. Chief Business Officer at Sonnet BioTherapeutics Holdings, Inc. (SONN). 2 reported Form 4/5 transactions since Sep 2024; latest on Dec 2, 2025. Located in PRINCETON, NJ.

Companies MCANDREW STEPHEN J has filed insider reports for

  • Sonnet BioTherapeutics Holdings, Inc. (SONN): Officer, Chief Business Officer
MCANDREW STEPHEN J profile photo

MCANDREW STEPHEN J

CIK: 0001227041

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Sonnet BioTherapeutics Holdings, Inc. logo
SONN

Sonnet BioTherapeutics Holdings, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Dec 2, 2025
    Disposition
    Direct
    6.4K shares-
  • Sonnet BioTherapeutics Holdings, Inc. logo
    SONN

    Sonnet BioTherapeutics Holdings, Inc.

    Jul 11, 2025
    Award
    Direct
    6K shares-

1-2 of 2